The metabolism of plasma glucose and catecholamines in Alzheimer's disease

H. Umegaki, N. Tamaya, Tadashi Shinkai, A. Iguchi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Several lines of evidence suggest that the cholinergic system in the hippocampus plays a pivotal roll in regulating the peripheral metabolism of glucose and catecholamines. The injection of cholinergic stimulators including neostigmine, the acetylcholine esterase inhibitor, into the third ventricle or the hippocampus induces the elevation of glucose or catecholamines in plasma in rats. Under stress conditions, release of acetylcholine in the hippocampus increases, which coincides with the elevation of plasma glucose and catecholamines. Age-related reduction in responsivity of the cholinergic system in the hippocampus has been well documented. The intrahippocampal neostigmine injection induces significantly attenuated responses in plasma glucose and catecholamines in rats, the finding suggested that changes in cholinergic system activity in the hippocampus could result in alteration of the peripheral metabolism of glucose and catecholamines. In Alzheimer's disease (AD), the most common type of dementia, degeneration of the hippocampal cholinergic system is one of the most robust pathological features. Measurement of plasma catecholamines during a fasting state in the groups of AD subjects, vascular dementia subjects, and non-demented control subjects showed significantly lower plasma epinephrine levels in the AD subjects. (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)1373-1382
Number of pages10
JournalExperimental Gerontology
Volume35
Issue number9-10
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Metabolism
Catecholamines
Cholinergic Agents
Plasmas
Glucose
Neostigmine
Acetylcholine
Rats
Esterases
Epinephrine

Keywords

  • Acetylcholine
  • Aging
  • Dementia
  • Hippocampus
  • Insulin
  • Stress

ASJC Scopus subject areas

  • Ageing
  • Medicine(all)

Cite this

The metabolism of plasma glucose and catecholamines in Alzheimer's disease. / Umegaki, H.; Tamaya, N.; Shinkai, Tadashi; Iguchi, A.

In: Experimental Gerontology, Vol. 35, No. 9-10, 2000, p. 1373-1382.

Research output: Contribution to journalArticle

Umegaki, H. ; Tamaya, N. ; Shinkai, Tadashi ; Iguchi, A. / The metabolism of plasma glucose and catecholamines in Alzheimer's disease. In: Experimental Gerontology. 2000 ; Vol. 35, No. 9-10. pp. 1373-1382.
@article{6c5c2d8dd73843bf8e8fecb1f643ebdf,
title = "The metabolism of plasma glucose and catecholamines in Alzheimer's disease",
abstract = "Several lines of evidence suggest that the cholinergic system in the hippocampus plays a pivotal roll in regulating the peripheral metabolism of glucose and catecholamines. The injection of cholinergic stimulators including neostigmine, the acetylcholine esterase inhibitor, into the third ventricle or the hippocampus induces the elevation of glucose or catecholamines in plasma in rats. Under stress conditions, release of acetylcholine in the hippocampus increases, which coincides with the elevation of plasma glucose and catecholamines. Age-related reduction in responsivity of the cholinergic system in the hippocampus has been well documented. The intrahippocampal neostigmine injection induces significantly attenuated responses in plasma glucose and catecholamines in rats, the finding suggested that changes in cholinergic system activity in the hippocampus could result in alteration of the peripheral metabolism of glucose and catecholamines. In Alzheimer's disease (AD), the most common type of dementia, degeneration of the hippocampal cholinergic system is one of the most robust pathological features. Measurement of plasma catecholamines during a fasting state in the groups of AD subjects, vascular dementia subjects, and non-demented control subjects showed significantly lower plasma epinephrine levels in the AD subjects. (C) 2000 Elsevier Science Inc.",
keywords = "Acetylcholine, Aging, Dementia, Hippocampus, Insulin, Stress",
author = "H. Umegaki and N. Tamaya and Tadashi Shinkai and A. Iguchi",
year = "2000",
doi = "10.1016/S0531-5565(00)00153-4",
language = "English",
volume = "35",
pages = "1373--1382",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",
number = "9-10",

}

TY - JOUR

T1 - The metabolism of plasma glucose and catecholamines in Alzheimer's disease

AU - Umegaki, H.

AU - Tamaya, N.

AU - Shinkai, Tadashi

AU - Iguchi, A.

PY - 2000

Y1 - 2000

N2 - Several lines of evidence suggest that the cholinergic system in the hippocampus plays a pivotal roll in regulating the peripheral metabolism of glucose and catecholamines. The injection of cholinergic stimulators including neostigmine, the acetylcholine esterase inhibitor, into the third ventricle or the hippocampus induces the elevation of glucose or catecholamines in plasma in rats. Under stress conditions, release of acetylcholine in the hippocampus increases, which coincides with the elevation of plasma glucose and catecholamines. Age-related reduction in responsivity of the cholinergic system in the hippocampus has been well documented. The intrahippocampal neostigmine injection induces significantly attenuated responses in plasma glucose and catecholamines in rats, the finding suggested that changes in cholinergic system activity in the hippocampus could result in alteration of the peripheral metabolism of glucose and catecholamines. In Alzheimer's disease (AD), the most common type of dementia, degeneration of the hippocampal cholinergic system is one of the most robust pathological features. Measurement of plasma catecholamines during a fasting state in the groups of AD subjects, vascular dementia subjects, and non-demented control subjects showed significantly lower plasma epinephrine levels in the AD subjects. (C) 2000 Elsevier Science Inc.

AB - Several lines of evidence suggest that the cholinergic system in the hippocampus plays a pivotal roll in regulating the peripheral metabolism of glucose and catecholamines. The injection of cholinergic stimulators including neostigmine, the acetylcholine esterase inhibitor, into the third ventricle or the hippocampus induces the elevation of glucose or catecholamines in plasma in rats. Under stress conditions, release of acetylcholine in the hippocampus increases, which coincides with the elevation of plasma glucose and catecholamines. Age-related reduction in responsivity of the cholinergic system in the hippocampus has been well documented. The intrahippocampal neostigmine injection induces significantly attenuated responses in plasma glucose and catecholamines in rats, the finding suggested that changes in cholinergic system activity in the hippocampus could result in alteration of the peripheral metabolism of glucose and catecholamines. In Alzheimer's disease (AD), the most common type of dementia, degeneration of the hippocampal cholinergic system is one of the most robust pathological features. Measurement of plasma catecholamines during a fasting state in the groups of AD subjects, vascular dementia subjects, and non-demented control subjects showed significantly lower plasma epinephrine levels in the AD subjects. (C) 2000 Elsevier Science Inc.

KW - Acetylcholine

KW - Aging

KW - Dementia

KW - Hippocampus

KW - Insulin

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=0033653759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033653759&partnerID=8YFLogxK

U2 - 10.1016/S0531-5565(00)00153-4

DO - 10.1016/S0531-5565(00)00153-4

M3 - Article

C2 - 11113615

AN - SCOPUS:0033653759

VL - 35

SP - 1373

EP - 1382

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 9-10

ER -